Magri, Caroline Jane
4 papers on CoChatORCID 0000-0002-9416-9397
Most cited papers
- Verified
2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 4,763
- Verified
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,642
- Verified
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., et al. (2023) · European Heart Journal
Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention
Cited by 329
- Verified
Gestational Glycemic Parameters and Future Cardiometabolic Risk at Medium-Term Follow Up
Xuereb, S., Magri, C. J., Xuereb, R. A., Xuereb, R. G., Galea, J., & Fava, S. (2019) · Canadian Journal of Diabetes
Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free